semaglutide and optic neuropathy linked to increased risk of vision loss in diabetes patients Anterior ischemic optic neuropathy in

The evidence is mixed

GLP-1 medications are being studied for brain-health and neurodegenerative conditions, but research protocols are not the same thing as informal microdosing claims

Suitability depends on factors such as BMI, medical history, existing health conditions and current medications rather than Hashimotos disease alone

Sanjeev Sockalingam, scientific director of Obesity Canada and chief medical officer at the Centre for Addiction and Mental Health in Toronto

Glia 70 , 12891300 (2022)

Each month includes your customized microdose, injection supplies, free shipping, and ongoing provider support no insurance needed